Differentiating Diabetes mellitus type 2 from other diseases: Difference between revisions
No edit summary |
|||
Line 32: | Line 32: | ||
|- | |- | ||
|style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Diabetes mellitus type 1|Type 1 Diabetes mellitus]] | |style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Diabetes mellitus type 1|Type 1 Diabetes mellitus]] | ||
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | |style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |'''↑''' | |style="padding: 5px 5px; background: #F5F5F5;" align="center" |'''↑''' | ||
Line 48: | Line 48: | ||
|- | |- | ||
|style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Diabetes mellitus type 2|Type 2 Diabetes mellitus]] | |style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Diabetes mellitus type 2|Type 2 Diabetes mellitus]] | ||
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | |style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |'''↑''' | |style="padding: 5px 5px; background: #F5F5F5;" align="center" |'''↑''' | ||
Line 64: | Line 64: | ||
|- | |- | ||
|style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[MODY]] | |style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[MODY]] | ||
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | |style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |'''↑''' | |style="padding: 5px 5px; background: #F5F5F5;" align="center" |'''↑''' | ||
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |'''↑''' | |style="padding: 5px 5px; background: #F5F5F5;" align="center" |'''↑''' | ||
Line 80: | Line 80: | ||
|- | |- | ||
|style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Psychogenic polydipsia]] | |style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Psychogenic polydipsia]] | ||
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | |style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | |style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 96: | Line 96: | ||
|- | |- | ||
|style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Diabetes insipidus]] | |style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Diabetes insipidus]] | ||
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
Line 128: | Line 128: | ||
|- | |- | ||
|style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Steroid]] therapy | |style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Steroid]] therapy | ||
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | |style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | |style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | |style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |'''↑''' | |style="padding: 5px 5px; background: #F5F5F5;" align="center" |'''↑''' | ||
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |'''↑''' | |style="padding: 5px 5px; background: #F5F5F5;" align="center" |'''↑''' | ||
Line 141: | Line 141: | ||
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |N/'''↑''' | |style="padding: 5px 5px; background: #F5F5F5;" align="center" |N/'''↑''' | ||
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |N/'''↑''' | |style="padding: 5px 5px; background: #F5F5F5;" align="center" |N/'''↑''' | ||
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Acanthosis nigricans|Acanthosis nigricans]] | |style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Acanthosis nigricans|Acanthosis nigricans,]] | ||
|- | |- | ||
|style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[RTA|RTA 1]] | |style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[RTA|RTA 1]] | ||
Line 147: | Line 147: | ||
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | |style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | |style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | |style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal | |style="padding: 5px 5px; background: #F5F5F5;" align="center" |Normal | ||
Line 180: | Line 180: | ||
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | |style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | |style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | | |style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |'''↑''' | |style="padding: 5px 5px; background: #F5F5F5;" align="center" |'''↑''' | ||
|style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | |style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 191: | Line 191: | ||
|style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Moon face]], [[obesity]], [[buffalo hump]], easy [[Bruising|bruisibility]] | |style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Moon face]], [[obesity]], [[buffalo hump]], easy [[Bruising|bruisibility]] | ||
|} | |} | ||
==References== | ==References== |
Revision as of 14:29, 30 March 2017
Diabetes mellitus type 2 Microchapters |
Differentiating Diabetes Mellitus Type 2 from other Diseases |
Diagnosis |
Treatment |
Medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Seyedmahdi Pahlavani, M.D. [2]
Overview
Type 2 diabetes mellitus must be differentiated from other disorders that may present with polyuria, polydipsia, weight loss or weight gain. Such disorders may include other forms of diabetes mellitus (e.g. type 1 DM, MODY) or other endocrine disorders (e.g. hypothyroidism, cushings syndrome, wolfram syndrome, alstrom syndrome) or drug
Differentiating Diabetes Mellitus Type 2 from other Diseases
Type 2 DM must be differentiated from other forms of diabetes mellitus as well as other endocrine disorders based on the syptoms and laboratory findings.[1][2][3] The following table shows the appropriate history and symptoms and laboratory findings that may distinguish type 2 DM from other diseases:
Disease | History and symptoms | Laboratory findings | Additional findings | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Polyuria | Polydipsia | Polyphagia | Weight loss | Weight gain | Serum glucose | Urinary Glucose | Urine PH | Serum Sodium | Urinary Glucose | 24 hrs cortisol level | C-peptide level | Serum glucagon | ||
Type 1 Diabetes mellitus | + | + | + | + | - | ↑ | ↑ | Normal | Normal | N/↑ | Normal | ↓ | Normal | Auto antibodies present (Anti GAD-65 and anti insulin anti bodies) |
Type 2 Diabetes mellitus | + | + | + | + | - | ↑ | ↑ | Normal | Normal | ↑ | Normal | Normal | ↑ | Acanthosis nigricans |
MODY | + | + | + | - | + | ↑ | ↑ | Normal | Normal | ↑ | Normal | Normal | N | - |
Psychogenic polydipsia | + | + | - | - | - | Normal | Normal | Normal | ↓ | Normal | Normal | Normal | Normal | - |
Diabetes insipidus | + | + | - | - | - | Normal | Normal | Normal | ↑ | Normal | Normal | Normal | Normal | - |
Transient hyperglycemia | - | - | - | - | - | ↑ | ↑ | Normal | Normal | ↑ | Normal | Normal | N/↑ | In hospitalized patients especially in ICU and CCU |
Steroid therapy | + | - | - | - | + | ↑ | ↑ | Normal | Normal | ↑ | ↑ | N/↑ | N/↑ | Acanthosis nigricans, |
RTA 1 | - | - | - | + | - | Normal | Normal | ↑ | Normal | ↑ | Normal | Normal | Normal | Hypokalemia, nephrolithiasis |
Glucagonoma | - | - | - | - | - | ↑ | Normal | Normal | Normal | - | Normal | Normal | ↑ | Necrolytic migratory erythema |
Cushing syndrome | - | - | - | - | + | ↑ | - | Normal | ↓ | N/↑ | ↑ | Normal | Normal | Moon face, obesity, buffalo hump, easy bruisibility |
References
- ↑ Barrett TG (2007). "Differential diagnosis of type 1 diabetes: which genetic syndromes need to be considered?". Pediatr Diabetes. 8 Suppl 6: 15–23. doi:10.1111/j.1399-5448.2007.00278.x. PMID 17727381.
- ↑ Type 1 Diabetes mellitus "Dennis Kasper, Anthony Fauci, Stephen Hauser, Dan Longo, J. Larry Jameson, Joseph Loscalzo"Harrison's Principles of Internal Medicine, 19e Accessed on December 27th,2016
- ↑ "namrata".